Business Description
Oxygenta Pharmaceutical Ltd
ISIN : INE102E01018
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -0.29 | |||||
Debt-to-Equity | -2.87 | |||||
Debt-to-EBITDA | -8.6 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 1.75 | |||||
Beneish M-Score | -0.74 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -33.8 | |||||
3-Year FCF Growth Rate | 8 | |||||
3-Year Book Growth Rate | 45.6 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.41 | |||||
9-Day RSI | 27.03 | |||||
14-Day RSI | 33.62 | |||||
6-1 Month Momentum % | 204.31 | |||||
12-1 Month Momentum % | 236.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.75 | |||||
Quick Ratio | 0.43 | |||||
Days Inventory | 117.77 | |||||
Days Sales Outstanding | 101.87 | |||||
Days Payable | 226.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -48.6 | |||||
Shareholder Yield % | 0.83 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 9.67 | |||||
Operating Margin % | -23.07 | |||||
Net Margin % | 0.05 | |||||
FCF Margin % | -37.03 | |||||
ROE % | Neg. Equity | |||||
ROA % | 0.03 | |||||
ROIC % | 0.04 | |||||
ROC (Joel Greenblatt) % | -30.61 | |||||
ROCE % | -31.97 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 319.7 | |||||
PE Ratio without NRI | 237.19 | |||||
PS Ratio | 5.68 | |||||
EV-to-EBIT | -34.34 | |||||
EV-to-EBITDA | -47.19 | |||||
EV-to-Revenue | 7.18 | |||||
EV-to-FCF | -19.38 | |||||
Price-to-Median-PS-Value | 6.3 | |||||
Earnings Yield (Greenblatt) % | -2.91 | |||||
FCF Yield % | -6.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Oxygenta Pharmaceutical Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 463.283 | ||
EPS (TTM) (₹) | 0.23 | ||
Beta | 0.14 | ||
Volatility % | 91.22 | ||
14-Day RSI | 33.62 | ||
14-Day ATR (₹) | 3.197333 | ||
20-Day SMA (₹) | 85.941 | ||
12-1 Month Momentum % | 236.63 | ||
52-Week Range (₹) | 26.01 - 108.64 | ||
Shares Outstanding (Mil) | 36.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Oxygenta Pharmaceutical Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Oxygenta Pharmaceutical Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Oxygenta Pharmaceutical Ltd Frequently Asked Questions
What is Oxygenta Pharmaceutical Ltd(BOM:524636)'s stock price today?
When is next earnings date of Oxygenta Pharmaceutical Ltd(BOM:524636)?
Does Oxygenta Pharmaceutical Ltd(BOM:524636) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |